• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年类风湿关节炎患者经皮冠状动脉介入治疗的结局:一项基于全国人群的队列研究

Outcomes of Percutaneous Coronary Intervention in Elderly Patients with Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study.

作者信息

Kim Bo Young, Moon HyeSung, Kim Sung-Soo, Kim Hyun-Sook

机构信息

Division of Rheumatology, Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung 25440, Republic of Korea.

Rexsoft Corp., Seoul 08826, Republic of Korea.

出版信息

Healthcare (Basel). 2023 May 10;11(10):1381. doi: 10.3390/healthcare11101381.

DOI:10.3390/healthcare11101381
PMID:37239666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10218010/
Abstract

Rheumatoid arthritis (RA) increases the risk of cardiovascular disease. This study aimed to evaluate the clinical outcomes of elderly patients with and without RA who underwent percutaneous coronary intervention (PCI). The Korean National Health Insurance Service claims database was used to extract data on 74,623 patients (14,074 with RA and 60,549 without RA) aged ≥ 65 years who were diagnosed with acute coronary syndrome and underwent PCI between 2008 and 2019. The primary outcome was survival of elderly patients with and without RA. The secondary outcome was survival in the RA subgroup. During a 10-year follow-up, the all-cause mortality survival rate was lower in patients with RA than that in patients without (53.7% vs. 58.3%, respectively, log-rank: < 0.001). In the all-cause mortality RA subgroup, patients with elderly-onset RA had poor survival outcomes, whereas patients with young-onset RA had good survival outcomes compared with that in patients without RA (48.1% vs. 73.7% vs. 58.3%, respectively, log-rank: < 0.001). Elderly patients with RA who underwent PCI had an increased mortality risk, particularly those with elderly rather than young-onset RA.

摘要

类风湿性关节炎(RA)会增加心血管疾病的风险。本研究旨在评估接受经皮冠状动脉介入治疗(PCI)的老年RA患者和非RA患者的临床结局。利用韩国国民健康保险服务索赔数据库,提取了2008年至2019年间74623例年龄≥65岁、被诊断为急性冠状动脉综合征并接受PCI治疗的患者的数据(14074例患有RA,60549例未患RA)。主要结局是患有和未患RA的老年患者的生存率。次要结局是RA亚组中的生存率。在10年随访期间,RA患者的全因死亡率生存率低于非RA患者(分别为53.7%和58.3%,对数秩检验:<0.001)。在全因死亡率RA亚组中,老年发病的RA患者生存结局较差,而年轻发病的RA患者与非RA患者相比生存结局较好(分别为48.1%、73.7%和58.3%,对数秩检验:<0.001)。接受PCI治疗的老年RA患者死亡风险增加,尤其是老年发病而非年轻发病的RA患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2a/10218010/57a2c78a6cbf/healthcare-11-01381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2a/10218010/b48f25dfa6fd/healthcare-11-01381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2a/10218010/e3134c90bf6c/healthcare-11-01381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2a/10218010/57a2c78a6cbf/healthcare-11-01381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2a/10218010/b48f25dfa6fd/healthcare-11-01381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2a/10218010/e3134c90bf6c/healthcare-11-01381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2a/10218010/57a2c78a6cbf/healthcare-11-01381-g003.jpg

相似文献

1
Outcomes of Percutaneous Coronary Intervention in Elderly Patients with Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study.老年类风湿关节炎患者经皮冠状动脉介入治疗的结局:一项基于全国人群的队列研究
Healthcare (Basel). 2023 May 10;11(10):1381. doi: 10.3390/healthcare11101381.
2
Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: A Korean nationwide cohort study.接受经皮冠状动脉介入治疗的类风湿关节炎患者的临床结局:一项韩国全国队列研究。
PLoS One. 2023 Feb 14;18(2):e0281067. doi: 10.1371/journal.pone.0281067. eCollection 2023.
3
Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.类风湿关节炎和系统性红斑狼疮患者经皮冠状动脉介入治疗的结局:一项为期 11 年的全国性队列研究。
Ann Rheum Dis. 2016 Jul;75(7):1350-6. doi: 10.1136/annrheumdis-2015-207719. Epub 2015 Aug 18.
4
Outcomes of Percutaneous Coronary Intervention in Patients With Rheumatoid Arthritis.类风湿关节炎患者经皮冠状动脉介入治疗的结局。
Am J Cardiol. 2021 Feb 1;140:39-46. doi: 10.1016/j.amjcard.2020.10.048. Epub 2020 Nov 2.
5
Outcomes of nonstenting percutaneous coronary intervention in patients with rheumatoid arthritis.类风湿关节炎患者行非支架经皮冠状动脉介入治疗的结局。
Am J Cardiol. 2012 Apr 15;109(8):1160-3. doi: 10.1016/j.amjcard.2011.11.056. Epub 2012 Jan 19.
6
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease.类风湿关节炎合并冠状动脉疾病患者的长期临床结局
Am J Cardiovasc Dis. 2017 Feb 15;7(1):9-18. eCollection 2017.
7
Characteristics of Radial Artery Coronary Bypass Graft Failure and Outcomes Following Subsequent Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后桡动脉冠状动脉旁路移植术失败的特点及结局。
JACC Cardiovasc Interv. 2023 Feb 27;16(4):457-467. doi: 10.1016/j.jcin.2022.11.035.
8
Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data.利用索赔数据对类风湿性关节炎患者听力损失风险进行的回顾性队列研究。
BMJ Open. 2018 Jan 5;8(1):e018134. doi: 10.1136/bmjopen-2017-018134.
9
Rheumatoid Arthritis is Not Associated with Increased Inpatient Mortality in Patients Admitted for Acute Coronary Syndrome.类风湿关节炎与急性冠脉综合征入院患者住院死亡率增加无关。
Cureus. 2020 Aug 17;12(8):e9799. doi: 10.7759/cureus.9799.
10
Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention.类风湿关节炎患者与接受经皮冠状动脉介入治疗的匹配受试者之间冠状动脉疾病的症状、治疗及结局比较。
Semin Arthritis Rheum. 2010 Dec;40(3):215-21. doi: 10.1016/j.semarthrit.2010.04.002. Epub 2010 Jun 11.

引用本文的文献

1
Percutaneous coronary intervention (PCI) in patients of rheumatoid arthritis(RA): A systematic review and meta-analysis.类风湿关节炎(RA)患者的经皮冠状动脉介入治疗(PCI):一项系统评价和荟萃分析。
Indian Heart J. 2025 Jan-Feb;77(1):7-13. doi: 10.1016/j.ihj.2024.12.002. Epub 2024 Dec 20.

本文引用的文献

1
Very Elderly Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的极老年急性冠状动脉综合征患者。
Heart Lung Circ. 2021 Sep;30(9):1337-1342. doi: 10.1016/j.hlc.2021.03.275. Epub 2021 Apr 23.
2
Outcomes of Percutaneous Coronary Intervention in Patients With Rheumatoid Arthritis.类风湿关节炎患者经皮冠状动脉介入治疗的结局。
Am J Cardiol. 2021 Feb 1;140:39-46. doi: 10.1016/j.amjcard.2020.10.048. Epub 2020 Nov 2.
3
Drug-Eluting Stents Versus Bare-Metal Stents in Large Coronary Artery Revascularization: Systematic Review and Meta-Analysis.
药物洗脱支架与金属裸支架在大冠状动脉血运重建中的比较:系统评价和荟萃分析。
Cardiovasc Revasc Med. 2021 Feb;23:42-49. doi: 10.1016/j.carrev.2020.07.018. Epub 2020 Jul 18.
4
Rheumatoid arthritis in the elderly: Characteristics and treatment considerations.老年人类风湿关节炎:特征与治疗注意事项。
Autoimmun Rev. 2020 Jun;19(6):102528. doi: 10.1016/j.autrev.2020.102528. Epub 2020 Mar 29.
5
Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.类风湿关节炎、系统性红斑狼疮和系统性硬化症患者的经皮冠状动脉介入治疗结局。
Rheumatology (Oxford). 2020 Sep 1;59(9):2512-2522. doi: 10.1093/rheumatology/kez639.
6
Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.全球、地区和国家类风湿关节炎负担 1990-2017 年:2017 年全球疾病负担研究的系统分析。
Ann Rheum Dis. 2019 Nov;78(11):1463-1471. doi: 10.1136/annrheumdis-2019-215920. Epub 2019 Sep 11.
7
Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.药物洗脱支架或金属裸支架经皮冠状动脉介入治疗:随机临床试验的系统评价和个体患者数据分析荟萃分析。
Lancet. 2019 Jun 22;393(10190):2503-2510. doi: 10.1016/S0140-6736(19)30474-X. Epub 2019 May 2.
8
Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry).比较老年患者(包括 10628 名 90 岁以上老人)经皮冠状动脉介入治疗的结果:来自日本全国注册登记研究(J-PCI 注册登记研究)的分析。
J Am Heart Assoc. 2019 Mar 5;8(5):e011183. doi: 10.1161/JAHA.118.011017.
9
Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry.与老年类风湿关节炎患者疾病活动度控制不足相关的风险因素:一项来自全国韩国风湿病学院生物制剂(KOBIO)登记处的研究结果。
PLoS One. 2018 Oct 16;13(10):e0205651. doi: 10.1371/journal.pone.0205651. eCollection 2018.
10
Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis.类风湿关节炎患者中生物制剂和 JAK 抑制剂的心血管安全性。
Curr Rheumatol Rep. 2018 May 30;20(7):42. doi: 10.1007/s11926-018-0752-2.